These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 26580456)

  • 21. Physicians' opinions following pharmacogenetic testing for psychotropic medication.
    Walden LM; Brandl EJ; Changasi A; Sturgess JE; Soibel A; Notario JF; Cheema S; Braganza N; Marshe VS; Freeman N; Tiwari AK; Kennedy JL; Müller DJ
    Psychiatry Res; 2015 Oct; 229(3):913-8. PubMed ID: 26298505
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacogenomic testing for neuropsychiatric drugs: current status of drug labeling, guidelines for using genetic information, and test options.
    Drozda K; Müller DJ; Bishop JR
    Pharmacotherapy; 2014 Feb; 34(2):166-84. PubMed ID: 24523097
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Use of plasmid-derived external quality control samples in pharmacogenetic testing.
    van der Straaten T; Swen J; Baak-Pablo R; Guchelaar HJ
    Pharmacogenomics; 2008 Sep; 9(9):1261-6. PubMed ID: 18781854
    [TBL] [Abstract][Full Text] [Related]  

  • 24. United States Food and Drug Administration Regulation of Gene and Cell Therapies.
    Bailey AM; Arcidiacono J; Benton KA; Taraporewala Z; Winitsky S
    Adv Exp Med Biol; 2015; 871():1-29. PubMed ID: 26374210
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacogenetic tests yield bonus benefit: better drug adherence.
    Dolgin E
    Nat Med; 2013 Nov; 19(11):1354-5. PubMed ID: 24202373
    [No Abstract]   [Full Text] [Related]  

  • 26. Establishing clinical utility of pharmacogenetic tests in the post-FDAAA era.
    Evans BJ
    Clin Pharmacol Ther; 2010 Dec; 88(6):749-51. PubMed ID: 21081943
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Germline genetic testing to predict drug response and toxicity in oncology--reality or fiction?
    Soh TI; Yong WP
    Ann Acad Med Singap; 2011 Aug; 40(8):350-5. PubMed ID: 22065000
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Current applications of clinical genetic testing for psychiatric practice.
    Mrazek DA
    Minn Med; 2007 Jan; 90(1):42-3. PubMed ID: 17305105
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Personalizing medicine with clinical pharmacogenetics.
    Scott SA
    Genet Med; 2011 Dec; 13(12):987-95. PubMed ID: 22095251
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nurses' genetic/genomics competencies when medication therapy is guided by pharmacogenetic testing: children with mental health disorders as an exemplar.
    Prows CA; Saldaña SN
    J Pediatr Nurs; 2009 Jun; 24(3):179-88. PubMed ID: 19467430
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tools for optimizing pharmacotherapy in psychiatry (therapeutic drug monitoring, molecular brain imaging and pharmacogenetic tests): focus on antidepressants.
    de Leon J
    Pharmacogenomics; 2021 Aug; 22(13):805-808. PubMed ID: 34344160
    [No Abstract]   [Full Text] [Related]  

  • 32. Pharmacogenetics: has the time come for pharmacists to embrace and implement the science?
    Beier MT; Panchapagesan M; Carman LE
    Consult Pharm; 2013 Nov; 28(11):696-711. PubMed ID: 24217190
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Translation of pharmacogenetic knowledge into cancer therapeutics.
    Yong WP; Innocenti F
    Clin Adv Hematol Oncol; 2007 Sep; 5(9):698-706. PubMed ID: 17982411
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An outsider's viewpoint: the FDA should regulate clinical pharmacogenetic/genomic tests, but...
    O'Kane D
    Clin Pharmacol Ther; 2010 Dec; 88(6):746-8. PubMed ID: 21081942
    [No Abstract]   [Full Text] [Related]  

  • 35. Regulatory approval for new pharmacogenomic tests: a comparative overview.
    Joly Y; Koutrikas G; Tassé AM; Issa A; Carleton B; Hayden M; Rieder MJ; Ramos-Paque E; Avard D
    Food Drug Law J; 2011; 66(1):1-24, i. PubMed ID: 24505844
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparing cytochrome P450 pharmacogenetic information available on United States drug labels and European Union Summaries of Product Characteristics.
    Reis-Pardal J; Rodrigues A; Rodrigues E; Fernandez-Llimos F
    Pharmacogenomics J; 2017 Dec; 17(6):488-493. PubMed ID: 27241061
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Can pharmacogenetics help rescue drugs withdrawn from the market?
    Shah RR
    Pharmacogenomics; 2006 Sep; 7(6):889-908. PubMed ID: 16981848
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 2023 FDA-approved psychotropic medications.
    Naguy A; Alayadhi N; Pridmore S; Alhazeem H; Alamiri B
    Asian J Psychiatr; 2023 Sep; 87():103684. PubMed ID: 37379646
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical implications of pharmacogenetic and microarray testing for advanced practice nurses.
    Brennan KS
    J Am Assoc Nurse Pract; 2015 May; 27(5):246-55. PubMed ID: 25755178
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacogenomic testing: relevance in medical practice: why drugs work in some patients but not in others.
    Kitzmiller JP; Groen DK; Phelps MA; Sadee W
    Cleve Clin J Med; 2011 Apr; 78(4):243-57. PubMed ID: 21460130
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.